Felodipine: An Overview
Felodipine is a member of the dihydropyridine class of
calcium channel blockers, primarily used to treat
hypertension and
angina pectoris. Marketed under various trade names such as Plendil, Felendil, and Cardioplen, it has been a staple in cardiovascular medicine since its development in the 1980s by the Swedish pharmaceutical company
AstraZeneca. The drug targets
voltage-gated L-type calcium channels, which are instrumental in regulating cardiac and smooth muscle contraction. By inhibiting these channels, Felodipine effectively reduces blood pressure and alleviates the workload on the heart.
Felodipine is particularly valued for its vasoselectivity, meaning it predominantly affects the peripheral vasculature with minimal impact on the heart's conduction system. This property makes it a favorable option for patients who need antihypertensive therapy without significant reductions in heart rate or contractility. Research on Felodipine continues, with numerous studies focusing on its long-term efficacy, safety profile, and potential benefits in treating other conditions such as
heart failure and
diabetic nephropathy.
Felodipine Mechanism of Action
The mechanism of action of Felodipine revolves around its ability to block L-type calcium channels located in the smooth muscle cells of the arterial walls. By inhibiting the influx of calcium ions, Felodipine induces relaxation of these smooth muscles, leading to vasodilation. This dilation reduces peripheral vascular resistance, which in turn lowers blood pressure. Additionally, by decreasing the afterload, the drug reduces the heart's oxygen demand, making it beneficial for treating angina.
Importantly, Felodipine exhibits a high degree of selectivity for vascular smooth muscle over cardiac muscle. This selectivity minimizes potential adverse effects on the heart's contractile function and electrical conduction system, making it a safer choice for many patients. The prolonged duration of action, typically lasting over 24 hours, allows for once-daily dosing, which can significantly improve patient compliance.
How to Use Felodipine
Felodipine is available in tablet form and is commonly prescribed for oral administration. The usual starting dose for treating hypertension is 5 mg once daily, although some patients may begin with 2.5 mg depending on their specific needs and tolerability. The dosage can be adjusted based on the patient's response, with the maximum recommended dose being 10 mg per day.
The onset of action for Felodipine is relatively quick, with a noticeable antihypertensive effect typically occurring within 2 to 5 hours after ingestion. However, it may take several weeks to achieve the full therapeutic effect, especially in the management of chronic conditions like hypertension. The extended-release formulation ensures a steady release of the drug over a 24-hour period, providing consistent blood pressure control.
It's essential to take Felodipine consistently at the same time each day, with or without food. However, it is advisable to avoid consuming grapefruit or grapefruit juice while on Felodipine, as this can significantly increase the drug's plasma concentration and potentially lead to adverse effects. Patients are encouraged to follow their healthcare provider’s instructions closely and not to discontinue the medication abruptly, as this can result in a rebound effect and spike in blood pressure.
What are Felodipine Side Effects
Like all medications, Felodipine can cause side effects, although not everyone will experience them. The most common side effects are generally mild and transient, often resolving as the body adjusts to the medication. These include
headache,
flushing,
dizziness, and
peripheral edema (
swelling of the ankles or feet). These effects are typically related to the vasodilatory action of the drug.
More serious but less common side effects may include
hypotension (excessively low blood pressure),
tachycardia (rapid heartbeat), and gastrointestinal disturbances such as
nausea and
abdominal pain. In rare cases, some patients may experience
gingival hyperplasia (
overgrowth of gum tissue), particularly with long-term use.
Felodipine is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should also be used with caution in patients with severe
aortic stenosis, as the reduction in blood pressure may exacerbate symptoms of this condition. Additionally, patients with a history of heart failure or
hepatic impairment should use Felodipine under close medical supervision, as these conditions can alter the drug's metabolism and excretion.
What Other Drugs Will Affect Felodipine
Felodipine can interact with several other medications, potentially altering its efficacy and safety profile. One of the most notable interactions is with
CYP3A4 inhibitors, such as
ketoconazole,
itraconazole,
erythromycin, and certain antiviral drugs. These agents can significantly increase the plasma concentration of Felodipine, heightening the risk of adverse effects like hypotension and dizziness.
Conversely, CYP3A4 inducers such as
rifampicin,
phenytoin, and
carbamazepine can decrease Felodipine levels, potentially reducing its antihypertensive effect. It is crucial for healthcare providers to be aware of these interactions and adjust dosages accordingly or consider alternative therapies.
Other medications that can affect Felodipine include beta-blockers, which may enhance its antihypertensive effects, and diuretics, which can also potentiate blood pressure-lowering effects. In patients receiving multiple antihypertensive agents, careful monitoring is essential to avoid excessive hypotension.
Additionally, nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect of Felodipine when used concurrently. Patients are advised to inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements, to manage potential interactions effectively.
In Conclusion
Felodipine has established itself as an effective and well-tolerated option for managing hypertension and angina pectoris. Its vasoselectivity, once-daily dosing, and favorable safety profile make it a valuable tool in cardiovascular medicine. However, like any medication, it requires careful consideration of potential side effects, contraindications, and drug interactions to ensure optimal therapeutic outcomes. Patients should work closely with their healthcare providers to tailor their treatment plans and monitor their progress regularly.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


